abstract |
The present invention relates to novel interleukin-2 proteins based on two or more amino acid substitutions in the N-terminal region of interleukin-2 protein, including fusion proteins, and more specifically circulated by these interleukin-2 proteins. It relates to a method for increasing the half-life. |